Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin- like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 10, 1996, Pages 3774-3782

  Tennant, Marie K ^a,b   Thrasher, J Brantley ^c   Twomey, Patrick A ^c   Drivdahl, Rolf H ^a,b   Birnbaum, R S ^b   Plymate, Stephen R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN;

ADENOCARCINOMA; ARTICLE; CANCER LOCALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALIGNANT TRANSFORMATION; MITOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; RNA ANALYSIS; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; AGED; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; RECEPTOR, IGF TYPE 1; RNA, MESSENGER;

EID: 0029826841     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.10.3774     Document Type: Article

References (42)

1. Daughaday WH, Rotwein P. 1989 Insulin-like growth factors 1 and 2. Peptide messenger ribonucleic acid, gene structures and serum and tissue concentrations. Endocr Rev. 10:68-91.
2. Roberts Jr CT, LeRoith D. 1988 Molecular aspects of insulin-like growth factor, their binding proteins, and receptors. Baillere Clin Endocrinol Metab. 2:1069-1085.
3. Cohick WS, Clemmons DR. 1992 The insulin-like growth factors. Annu Rev Physiol. 55:131-153.
4. Daughaday WH. 1990 Editorial: the possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology. 127:1-4.
5. Rechler MM, Nissley SP. 1985 The nature and regulation of the receptors for the insulin-like growth factor. Annu Rev Physiol. 47:425-442.
6. Rosenfeld RG. 1987 Somatomedin action and tissue growth-factor receptors. In: Robbins RJ, Melmed S, eds. Acromegaly. New York: Plenum Press; 45-53.
7. Chernausek SD, Jacobs S, Van Wyk JJ- 1981 Structural similarities between human receptors for somatomedin C and insulin: analysis by affinity labeling. Biochemistry. 20:7345-7350.
8. Jacobs S, Kull FC, Earo HS, Svoboda ME, Van Wyk JJ, Cuatrecasas PP. 1983 Somatomedin C stimulates the phosphorylation of the β-subunit of its own receptor. J Biol Chem. 258:9581-9584.
9. Ullrich A, Gray A, Tam QW, Yang-Feng T, Tsubokawa M, Collins C. 1986 Insulin-like growth factor 1 receptor primary structure: comparison with insulin receptor suggests structural determinants that define specificity. EMBO J. 5:2503-2512.
10. Cohen P, Peehl DM, Lamson G, Rosenfeld RG. 1991 Insulin-like growth factors (IGFs), IGF receptors, and IGF binding proteins in primary cultures of epithelial cells. J Clin Endocrinol Metab. 73:401-407.
11. Fiorelli G, de Bellis A, Longo A, et al. 1991 Growth factors in the human prostate. J Steroid Biochem Mol Biol. 40:199-205.
12. Fiorelli G, de Bellis A, Longo A, et al. 1991 Insulin-like growth factor-1 receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J Clin Endocrinol Metab. 72:740-746.
13. Cohen P, Peehl DM, Baker B, Liu F, Hintz RL, Rosenfeld RG. 1994 Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrinol Metab. 79:1410-1415.
14. Bonnet P, Reiter E, Bruyninx M, et al. 1993 Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5α-reductase and steroid hormone receptors messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J Clin Endocrinol Metab. 77:1203-1208.
15. Boudon C, Rodier G, Lechevallier E, Mottet N, Barenton B, Sultan Ch. 1996 Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture. J Clin Endocrinol Metab. 81:612-617.
16. Angelloz-Nicoud P, Binoux M. 1995 Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology. 136:5485-5492.
17. Figueroa JA, Adrìan VL, Jackson JG, Yee D. 1995 Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine growth loop. J Clin Endocrinol Metab. 80:3476-3482.
18. Barni T, Vannelli BG, Sadri R, et al. 1994 Insulin-like growth factor (IGF-I) and its binding protein IGFBP-4 in human prostatic hyperplastic tissue: gene expression and its cellular localization. J Clin Endocrinol Metab. 78:778-783.
19. Pietrzkowski Z, Mulholland G, Comella L, Jameson BA, Wernicke D, Baserga R. 1991 Inhibition of growth of prostatic cancer cell lines by peptides analogues of insulin-like growth factor 1. Cancer Res. 53:1102-1106.
20. Pekonen F, Partanen S, Makinen T, Rutaned E-M. 1988 Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res. 48:1343-1347.
21. Papa V, Gliozzo B, Clark GM, et al. 1993 Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res. 53:3736-3740.
22. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Kore M. 1995 Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res. 55:2007-2011.
23. Tanaka R, Tsushima T, Murakami H, Shizume K, Obara T. 1994 Insulin-like growth factor I receptors and insulin-like growth factor-binding proteins in human parathyroid tumors. World J Surg. 18:635-642.
24. Tennant MK, Thrasher JB, Twomey PA, Birnbaum RS, Plymate SR. 1996 Insulin-like growth factor-binding protein-2 and -3 expression in benign hu-man prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. J Clin Endocrinol Metab. 81:411-420.
25. Petein M, Michel P, Velthoven RV, et al. 1991 Morphonnuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis. Am J Clin Pathol. 96:628-634.
26. McNeal JE. 1988 Significance of duct-acinar dysplasia in prostate carcinogenesis. Prostate. 13:91-102.
27. Bostwick DG. 1992 Prostatic intraepithelial neoplasia (PIN): current concepts. J Cell Biochem. 16(SuPPl):10-19.
28. Brawer MK. 1992 Prostatic intraepithelial neoplasia. A premalignant lesion. Hum Pathol. 23:242-248.
29. Mostofi FK, Davis Jr CJ, Sesterhenn IA. 1993 Histopathology of prostate cancer, In: Lepor H, Lawson R, eds. Prostate diseases. Philadelphia: Saunders; 229-256.
30. Cohen P, Peehl DM, Rosenfeld RG. 1994 The IGF axis in the prostate. Horm Metab Res. 26:81-84.
31. Quinn LS, Steinmetz B, Maas A, Ong L, Kaleko M. 1994 Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation. J Cell Physiol. 159:387-398.
32. Florini JR, Ewton DZ, Falen SL, Van Wyk JJ. 1986 Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins. Am J Physiol. 250:C771-C778.
33. Schneid H, Seurin D, Noguiez P, LeBouc Y. 1992 Abnormalities of insulin-like growth factor (IGF-I and IGF-II) genes in human tumor tissue. Growth Regul. 2:45-54.
34. Yun K. 1993 Clear cell sarcoma of the kidney expresses insulin-like growth factor-II but not WT1 transcripts. Am J Pathol. 142:39-47.
35. Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT, Cullen KJ. 1995 Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Cancer Res. 55:2448-2454.
36. Baserga R. 1995 The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55:249-252.
37. Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A, Baserga R. 1993 Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor. Proc Natl Acad Sci USA. 90:11217-11221.
38. Sell C, Dumenil G, Deveaud C, et al. 1994 Effect of a null mutation of the type 1 IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol. 14:3604-3612.
39. Baserga R, Sell C, Porcu P, Rubini M. 1994 The role of the IGF-I receptor in the growth and transformation of mammalian cell. Cell Prolif, 27:63-71.
40. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R. 1994 Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res. 54:4848-4850.
41. Rosenfeld R, Hintz R. 1980 Characterization of a specific receptor for somatomedin-C (SM-C) on cultured human lymphocytes: evidence that SM-C modulates homologous receptor concentration. Endocrinology. 107: 1841-1848.
42. Rosenfeld R, Dollar L. 1982 Characterization of the somatomedin-C/insulin-like growth factor I(SM-C/IGF-I) receptor on cultured human fibroblast monolayers: regulation of receptor concentrations by SM-C/IGF-I and insulin. J Clin Endocrinol Metab. 55:434-440.